Your browser doesn't support javascript.
loading
Exacerbated prognostic impact of multiple intramural metastasis versus single intramural metastasis of thoracic esophageal squamous cell carcinoma: evidence from an Uzbekistan cohort.
Yusupbekov, Abrorjon; Shinozuka, Takahiro; Juraev, Elyor; Usmanov, Bekzod; Kanda, Mitsuro; Sakamoto, Junichi; Tuychiev, Otabek.
Affiliation
  • Yusupbekov A; Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology (National Cancer Center of Uzbekistan), Tashkent, Uzbekistan.
  • Shinozuka T; Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. tshinozuka@med.nagoya-u.ac.jp.
  • Juraev E; Department of Esophageal and Stomach Oncology, Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology (National Cancer Center of Uzbekistan), Tashkent, Uzbekistan.
  • Usmanov B; Department of Oncology and Hematology, Tashkent State Pediatric Institute, Tashkent, Uzbekistan.
  • Kanda M; Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
  • Sakamoto J; Tokai Central Hospital, Kakamigahara, Japan.
  • Tuychiev O; Department of Thoracic Surgical Oncology, Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology (National Cancer Center of Uzbekistan), Tashkent, Uzbekistan.
Surg Today ; 54(7): 771-778, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38193909
ABSTRACT

PURPOSE:

Intramural metastasis (IM) is a poor prognostic factor for patients with esophageal squamous cell carcinoma (ESCC). We conducted this study to assess the prognostic impact of IM in an Uzbekistan cohort and to identify the factors associated with the poor prognosis of patients with ESCC and IM.

METHODS:

The subjects of this retrospective analysis were 1083 patients with thoracic ESCC, who underwent curative esophagectomy between 2001 and 2021 at the National Cancer Center of Uzbekistan. We compared the clinicopathological characteristics and survival outcomes of patients with versus those without IM and evaluated the factors associated with the poor prognosis of patients with IM.

RESULTS:

Patients with pathological IM (n = 59, 5.4%) were significantly older, had a higher percentage of lymphatic invasion and worse pathological N stage, and had shorter overall survival (OS) than patients without IM. Multivariable analysis of OS identified multiple IMs as the only independent prognostic factor in patients with IM (hazard ratio, 6.04; 95% confidence interval, 2.77-13.18; P < 0.001). Patients with multiple IMs had shorter OS and recurrence-free survival than those with a single IM.

CONCLUSION:

IM was a poor prognostic factor for patients with ESCC in this Uzbekistan cohort and multiple IMs were associated with worse outcomes.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Esophagectomy / Esophageal Squamous Cell Carcinoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia / Europa Language: En Journal: Surg Today Year: 2024 Type: Article Affiliation country: Uzbekistan

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Esophagectomy / Esophageal Squamous Cell Carcinoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia / Europa Language: En Journal: Surg Today Year: 2024 Type: Article Affiliation country: Uzbekistan